Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
Meghan Scanlon, insider at Boston Scientific
Meghan Scanlon Insider Alerts

Get notified the next time Meghan Scanlon buys or sells Boston Scientific stock. Enter your email address below to get our daily insider buying and selling report.

Meghan Scanlon Insider Information

Meghan Scanlon is our senior vice president and president, Urology and Pelvic Health, a position she has held since February 2020. In this role, she is responsible for developing and bringing to market innovative, industry-leading solutions for urological, urogynecological, and gynecological diseases. Prior to her current role, Ms. Scanlon served as vice president and general manager for the global Urology and Pelvic Health commercial organization, with responsibility for overseeing the stone, prostate health, prosthetic urology and women’s health franchises. She is a member of the Global Council for Inclusion and serves as the executive sponsor for our PRIDE employee resource group, which is a network of LGBTQ+ employees and allies that fosters inclusiveness and professional fulfillment through corporate and community LGBTQ+ programs and initiatives. Since joining Boston Scientific in 2014 as vice president, global marketing for Endoscopy, she has progressed through roles of increasing responsibility in Urology and Pelvic Health and Endoscopy, and played a significant role in driving and shaping the global commercial organization structures and portfolio innovation strategies for both businesses. Prior to joining Boston Scientific, Ms. Scanlon spent nearly 15 years in leadership roles within the Johnson & Johnson medical device business and started her early career as a design engineer at Gillette. She holds a B.S. in Mechanical Engineering from Tufts University and both her M.B.A. and M.S.M.E. from Massachusetts Institute of Technology.

What is Meghan Scanlon's net worth?

The estimated net worth of Meghan Scanlon is at least $1.35 million as of June 24th, 2021. Ms. Scanlon owns 34,280 shares of Boston Scientific stock worth more than $1,352,689 as of December 5th. This net worth evaluation does not reflect any other investments that Ms. Scanlon may own. Learn More.

How do I contact Meghan Scanlon?

The corporate mailing address for Ms. Scanlon and other Boston Scientific executives is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. Boston Scientific can also be reached via phone at (508) 683-4000 and via email at [email protected]

Has Meghan Scanlon been buying or selling shares of Boston Scientific?

Meghan Scanlon has not been actively trading shares of Boston Scientific during the past quarter. Most recently, Meghan Scanlon sold 13,850 shares of the business's stock in a transaction on Tuesday, July 27th. The shares were sold at an average price of $45.01, for a transaction totalling $623,388.50.

Who are Boston Scientific's active insiders?

Boston Scientific's insider roster includes Arthur Butcher (EVP), Wendy Carruthers (SVP), Jodi Eddy (SVP), Joseph Fitzgerald (EVP), Edward Mackey (EVP), Michael Mahoney (CEO), Jeffrey Mirviss (EVP), Jonathan Monson (CAO), Maulik Nanavaty (SVP), Scott Olson (SVP), David Pierce (EVP), Meghan Scanlon (SVP), John Sorenson (SVP), Eric Thepaut (EVP), and David Wichmann (Director).

Are insiders buying or selling shares of Boston Scientific?

During the last twelve months, Boston Scientific insiders bought shares 1 times. They purchased a total of 25,000 shares worth more than $1,049,500.00. During the last twelve months, insiders at the medical equipment provider sold shares 33 times. They sold a total of 1,330,818 shares worth more than $56,960,608.65. The most recent insider tranaction occured on November, 15th when Director David S Wichmann bought 25,000 shares worth more than $1,049,500.00. Insiders at Boston Scientific own 0.7 % of the company.

Information on this page was last updated on 11/15/2021.

Meghan Scanlon Insider Trading History at Boston Scientific

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/27/2021Sell13,850$45.01$623,388.50View SEC Filing Icon  
6/24/2021Sell16,450$44.03$724,293.5034,280View SEC Filing Icon  
See Full Table

Meghan Scanlon Buying and Selling Activity at Boston Scientific

This chart shows Meghan Scanlon's buying and selling at Boston Scientific by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Boston Scientific Company Overview

Boston Scientific logo
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Read More

Today's Range

Now: $39.46
Low: $38.98
High: $40.09

50 Day Range

MA: $42.30
Low: $38.07
High: $44.87

2 Week Range

Now: $39.46
Low: $33.42
High: $46.28

Volume

8,704,034 shs

Average Volume

8,645,113 shs

Market Capitalization

$56.23 billion

P/E Ratio

54.05

Dividend Yield

N/A

Beta

0.87
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!